N-acetylcysteine amide

DRUG2 trials

Sponsors

Nacuity Pharmaceuticals, Inc.

Conditions

CystinosisRetinitis Pigmentosa (RP)Usher Syndrome

Phase 1

PK and PD Study of NPI-001 and Cysteamine Bitartrate

Active, not recruitingNCT05994534

Nacuity Pharmaceuticals, Inc.Cystinosis

Start: 2023-10-29End: 2026-08-01Target: 12Updated: 2026-06-30

Phase 3

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Not yet recruitingNCT07290530

Nacuity Pharmaceuticals, Inc.Retinitis Pigmentosa (RP), Usher Syndrome

Start: 2026-12-01End: 2029-07-01Target: 80Updated: 2026-07-01